Evidence map›Paper›PMID 41834392›Full record

ArticleACS applied materials & interfaces2026

Nanoarchitectonics of Metal-Organic Framework Platforms for Enhanced Enzyme Delivery with Preserved Activity.

Il-Chul Yoon, Hyejoo Kim, Geelsu Hwang

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Il-Chul YoonDepartment of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Hyejoo KimDepartment of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Geelsu HwangDepartment of Preventive and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0001-7277-5639

Funding

Translational Multimodal Strategy for Peri-Implant Disease PreventionR01DE032343 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI Geelsu Hwang, Albert Kim · 2023 to 2026
$2.1M
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric BiomaterialR21DE032162 · NIDCR · UNIVERSITY OF PENNSYLVANIA · PI HWANG, GEELSU · 2023 to 2024
$440k
NIDCR NIH HHS R01 DE032343NIDCR NIH HHS R21 DE032162
6 · The paper itself

Abstract

The targeted delivery of biomacromolecules remains a critical challenge due to their intrinsic instability, limited permeability across biological barriers, and susceptibility to degradation. Herein, we report postsynthetic enzyme encapsulation in reaction-mechanism-guided metal-organic framework nanocarriers (MOF NCs), enabling selective loading, controlled release, and preserved biological function. The MOF NCs were synthesized via coordination-driven assembly, yielding hybridized porous architectures with high colloidal stability in aqueous media. Enzyme encapsulation was accomplished through nondisruptive interactions, including hydrogen bonding, ionic interactions, covalent anchoring, or van der Waals interactions. The structural integrity of β-Dextranase and endo-1,4-β-mannanase, enzymes known to disrupt oral biofilms, was maintained throughout encapsulation and release, as confirmed by circular dichroism spectroscopy. Environmentally responsive enzyme release was triggered under mildly acidic or alkaline conditions, driven by ligand exchange and hydrolysis at the zinc coordination centers, leading to nanocarrier disassembly and subsequent enzymatic activation. The MOF NCs exhibited excellent biocompatibility and preserved enzyme activity comparable to free enzymes at acidic and basic pH values, demonstrating their potential for targeted therapeutic applications at otherwise inaccessible biological sites.

Indexed as

beta-MannosidaseDrug CarriersMetal-Organic FrameworksHumansHydrogen-Ion Concentrationbeta-MannosidaseDrug CarriersMetal-Organic Frameworksbiomacromolecule deliveryenzyme encapsulationmetal−organic framework nanocarriersnanoarchitectonicspH-triggered releasepostsynthetic modification

Identifiers

PMID41834392
PMCPMC13076066

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.